Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4, indicating a new build/update of the page.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded related topics entries, including a Schizophrenia topic and a MedlinePlus Genetics reference, to improve cross-linking to related topics and genetics resources.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page's revision label was updated to v3.6.4, indicating a small backend/content update to the page.SummaryDifference0.0%

- Check34 days agoChange DetectedTopic tags were updated to remove Schizophrenia and the related topics MedlinePlus Genetics. This change narrows the subject associations presented for the study on this page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, indicating a small patch or update to the page.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a version update to the page rather than a substantive change to the study information.SummaryDifference0.0%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.